GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a significant focus in therapeutic research, largely due to its remarkable impact on treating conditions such as adult-onset diabetes and weight gain. Recent studies have demonstrated that more than glucose control, GLP-1 medications offer promise for circulatory well-being